📰 Practice Guidelines News
Page 52 - Practice Guidelines News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Practice Guidelines. Real-time updates on events, politics, business and more.
October 13, 2021
/PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines for Patients® Basal Cell Skin Cancer...
October 8, 2021
Argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings - read this article along with other careers information, tips and advice on BioSpace
October 4, 2021
/PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) will conduct a three-day, live virtual congress October 14-16, 2021 addressing the latest in...
October 1, 2021
Whether or not late stage patients have access to the latest therapies or only cytotoxic chemotherapy; the treatment options are still only palliative and symptomatic. Symptomatic care refers to therapies intended to ease the symptoms and improve the patient’s quality of life (QoL) without addressing the basic cause of the disease.
October 1, 2021
Though Ireland was making progress in the management of cervical cancer – albeit from a low position internationally – the pandemic has taken its toll
September 16, 2021
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and...
September 12, 2021
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA)...
August 14, 2021
From time immemorial, Sri Lanka has been well known for its hospitality, and we have on record many accolades from visitors in the annals of Sri Lankan history including Far Hein, Mark Twain, and Marc | eTurboNews | Trends | Travel News
August 10, 2021
/PRNewswire/ -- As per the Global Idiopathic Pulmonary Fibrosis (IPF)Market research report published by Astute Analytica, the market is expected to grow at a...
August 5, 2021
Kadmon Announces REZUROCK(TM) (belumosudil) Added to National Comprehensive Cancer Network(R) Clinical Practice Guidelines in Oncology for Hematopoietic Cell Transplantation ACCESSWIRE 05 Aug 2021, 06:05 GMT+10 NEW YORK, NY / ACCESSWIRE / August 4, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that the National Comprehensive Cancer Network ® (NCCN) added REZUROCK TM (belumosudil) tablets to its NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Hematopoietic Ce...